statistiche ricercatore

CHINELLO, CLIZIA

Distribuzione geografica

Continente	#
NA - Nord America	7922
EU - Europa	3709
AS - Asia	709
SA - Sud America	19
Continente sconosciuto - Info sul continente non disponibili	11
OC - Oceania	6
AF - Africa	5
Totale	12381

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	7766
IT - Italia	999
DE - Germania	970
SE - Svezia	592
CN - Cina	528
UA - Ucraina	226
AT - Austria	224
GB - Regno Unito	202
CA - Canada	154
IE - Irlanda	98
VN - Vietnam	86
DK - Danimarca	82
BE - Belgio	81
FR - Francia	54
FI - Finlandia	49
RU - Federazione Russa	39
IN - India	36
TR - Turchia	21
NL - Olanda	20
PL - Polonia	19
ES - Italia	14
RO - Romania	14
BR - Brasile	10
EU - Europa	10
IR - Iran	10
KR - Corea	9
AU - Australia	6
CZ - Repubblica Ceca	6
BG - Bulgaria	5
CH - Svizzera	4
CL - Cile	4
GR - Grecia	4
PH - Filippine	4
AR - Argentina	3
NO - Norvegia	3
SA - Arabia Saudita	3
SG - Singapore	3
HR - Croazia	2
IL - Israele	2
JP - Giappone	2
LU - Lussemburgo	2
MA - Marocco	2
A2 - ???statistics.table.value.countryCode.A2???	1
AZ - Azerbaigian	1
BT - Bhutan	1
EC - Ecuador	1
EG - Egitto	1
KZ - Kazakistan	1
MU - Mauritius	1
MY - Malesia	1
PA - Panama	1
PE - Perù	1
PR - Porto Rico	1
SC - Seychelles	1
UZ - Uzbekistan	1
Totale	12381

Salva come PNG Salva come JPEG

Città	#
Ann Arbor	2127
Fairfield	773
Frankfurt am Main	739
Chandler	722
Woodbridge	626
Wilmington	530
Houston	506
Milan	446
Dearborn	358
Ashburn	311
Seattle	305
Cambridge	244
Jacksonville	233
Vienna	222
Princeton	175
Nanjing	134
Dublin	98
Brussels	78
Lawrence	63
Altamura	62
Fremont	59
Nanchang	56
Beijing	51
Dong Ket	48
Lachine	40
San Diego	39
Montréal	38
Guangzhou	37
Ottawa	35
Shenyang	28
Toronto	27
Andover	25
Hebei	23
Lissone	23
Zhengzhou	20
Falls Church	19
Kunming	19
Tianjin	19
Jiaxing	18
Jinan	18
Changsha	16
Chicago	16
Norwalk	16
Ningbo	15
Pavia	15
Boardman	14
Brescia	14
Edmonton	14
Shanghai	14
Kiev	13
Ripalta Cremasca	13
London	12
Los Angeles	9
Mountain View	9
Philadelphia	9
Taizhou	9
Huizen	8
Napoli	8
Bergamo	7
Cinisello Balsamo	7
Nürnberg	7
Rome	7
Sacramento	7
Verona	7
Atlanta	6
Hanover	6
Kraków	6
Legnano	6
Lodi	6
Redmond	6
San Mateo	6
Segrate	6
Augusta	5
Birmingham	5
Cardano al Campo	5
Como	5
Daejeon	5
Hefei	5
Helsinki	5
Lanzhou	5
Piemonte	5
Plovdiv	5
San Giuliano Milanese	5
Brno	4
Cagliari	4
Catanzaro	4
Dallas	4
Edinburgh	4
Genova	4
Haikou	4
Hangzhou	4
Kocaeli	4
Leawood	4
Mersin	4
Muggiò	4
Nova Milanese	4
Padova	4
Phoenix	4
San Francisco	4
Vigevano	4
Totale	9831

Salva come PNG Salva come JPEG

Nome	#
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging	388
Comparative membrane proteomics: A technical advancement in the search of renal cell carcinoma biomarkers	339
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier	314
Differential protein profiling of renal cell carcinoma urinary exosomes	297
Urinary exosomes and diabetic nephropathy: a proteomic approach	269
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma	269
Effects of Hematuria on the Proteomic Profile of Urinary Extracellular Vesicles: Technical Challenges	241
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time	240
A novel versatile precursor suitable for 18F-radiolabeling via “click chemistry”	235
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue	232
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades	230
Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression	223
The proteomic landscape of renal tumors	219
Serum biomarkers of Renal Cell Carcinoma assessed using a protein profiling approach based on ClinProt technique	214
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall	213
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine	212
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies	204
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy	201
Robust conclusions in mass spectrometry analysis	197
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays	197
Mutual Information Optimization for Mass Spectra Data Alignment	197
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine	194
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing	193
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture	192
The putative role of MALDI-MSI in the study of Membranous Nephropathy	188
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC	185
Urinary extracellular vesicles and salt-losing tubulopathies: A proteomic approach	184
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder	180
Tumor size, stage and grade alterations of urinary peptidome in RCC	177
Different expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy	174
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry	169
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches	167
Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3	164
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues	161
Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery	159
Proteome analysis in thyroid pathology	157
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions	156
Analysis of correlation structures in renal cell carcinoma patient data	155
An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid Carcinoma	153
Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors	152
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy	149
Imaging mass spectrometry: a new tool for kidney disease investigations	147
Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples	145
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation	140
A Mutual Information Approach to Data Integration for Alzheimer’s Disease Patients	138
Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach	136
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE	132
A Support Vector Machine Classification of Thyroid Bioptic Specimens Using MALDI-MSI Data	132
Intraluminal proteome and peptidome of human urinary extracellular vesicles	129
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies	128
Towards the standardization of mitochondrial proteomics: the Italian mt-HPP initiative	127
The urinary proteome and peptidome of renal cell carcinoma patients: A comparison of different techniques	126
Human urine biomarkers of renal cell carcinoma evaluated by ClinProt	123
Detection of high molecular weight proteins by MALDI imaging mass spectrometry	123
Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis	121
Proteomics imaging and the kidney	116
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging	115
Modulation of urinary peptidome in humans exposed to high altitude hypoxia	109
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers	109
A molecular imaging approach to individuate tumour infiltrating lymphocytes	109
AQP1 expression analysis in human diseases: Implications for proteomic characterization	107
Immunoreattività e carcinoma renale	101
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging	101
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions	98
Characterization of distinguishing regions for Renal Cell Carcinoma discrimination	95
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer	94
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome	89
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies	87
Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry	86
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies	85
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach	81
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood	74
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions	74
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI	68
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI	65
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions	64
Method for the in vitro diagnosis of thyroid diseases	64
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference	60
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies	56
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role?	56
Identification of aberrant serum IgG glycoforms in Idiopathic membranous nephropathy	56
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach.	51
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS	47
Tri-modal MALDI-MS imaging of lipids, N-Glycans, and proteins on a single tissue section	46
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role?	45
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine?	42
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics	41
Delving deeper into the tissue proteome: improving cell-specificity with high spatial resolution MALDI-MS Imaging	41
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease	38
Towards lipid MALDI-MS imaging in FFPE tissue: antigen retrieval and its effect on positive ion species	36
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species	34
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients.	30
A Blood Bank Standardized Production of Human Platelet Lysate for Mesenchymal Stromal Cell Expansion: Proteomic Characterization and Biological Effects	29
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section	26
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation	13
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model	10
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma	10
Totale	13145

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	22181
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	22181

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2017/2018	80	0	0	0	0	0	0	0	0	0	0	31	49
2018/2019	1421	49	34	63	18	65	101	115	66	102	165	285	358
2019/2020	2884	304	190	182	226	250	349	434	209	267	202	195	76
2020/2021	2733	122	148	294	286	220	225	329	292	205	224	154	234
2021/2022	1539	145	146	134	196	79	127	54	96	60	123	149	230
2022/2023	3025	299	818	282	322	148	416	96	241	219	80	104	0
Totale													13145

Bicocca Open Archive

CHINELLO, CLIZIA

Distribuzione geografica